Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 Apr 22;35(7):S49–S55. doi: 10.1016/j.arth.2020.04.052

The Effect of the COVID-19 Pandemic on Electively Scheduled Hip and Knee Arthroplasty Patients in the United States

Timothy S Brown a,, Nicholas A Bedard a, Edward O Rojas a, Christopher A Anthony b, Ran Schwarzkopf c, C Lowry Barnes d, Jeffrey B Stambough d, Simon C Mears d, Paul K Edwards d, Sumon Nandi e, Hernan A Prieto f, Javad Parvizi g; AAHKS Research Committee
PMCID: PMC7195093  PMID: 32376163

Abstract

Background

In response to the COVID-19 pandemic, hospitals in the United States were recommended to stop performing elective procedures. This stoppage has led to the cancellation of a large number of hip and knee arthroplasties. The effect of this on patients’ physical mental and economic health is unknown.

Methods

A survey was developed by the AAHKS Research Committee to assess pain, anxiety, physical function, and economic ability of patients to undergo a delayed operation. Six institutions conducted the survey to 360 patients who had to have elective hip and knee arthroplasty cancelled between March and July of 2020.

Results

Patients were most anxious about the uncertainty of when their operation could be rescheduled. Although 85% of patients understood and agreed with the public health measures to curb infections, almost 90% of patients plan to reschedule as soon as possible. Age and geographic region of the patients affected their anxiety. Younger patients were more likely to have financial concerns and concerns about job security. Patients in the Northeast were more concerned about catching COVID-19 during a future hospitalization.

Conclusions

Patients suffering from the pain of hip and knee arthritis continue to struggle with pain from their end-stage disease. They have anxiety about the COVID-19 pandemic. Few patients feel they will be limited financially and 90% want to have surgery as soon as possible. Age and physical location of the patients affect their causes for anxiety around their future surgery.

Keywords: total hip arthroplasty, total knee arthroplasty, COVID-19, surgery cancellation, pandemic


The 2020 global pandemic caused by the novel coronavirus SARS-CoV-2 (COVID-19) [1] has had drastic effects across world economies and healthcare systems [2,3]. With the rapid spread across the globe, many regions were overwhelmed with patients requiring respiratory support [[4], [5], [6]]. Public health interventions in China provided guidance for other regions in the world on how to face a looming worldwide crisis [7]. After the first identified infection in the United States (US) in late January 2020 and subsequent evidence of community spread, state governments began drastically limiting businesses and issuing stay-at-home orders. Hospitals began limiting elective surgical procedures following national health guidelines in an effort to (1) slow the spread of the disease, (2) protect patients and staff from asymptomatic or undiagnosed carriers, (3) conserve personal protective equipment, and (4) reserve inpatient capacity for the COVID-19 infections [8,9]. With the World Health Organization declaration of a global pandemic on March 11, 2020, elective cases in the US, including hip and knee arthroplasty, began to be postponed indefinitely or canceled outright. The US Surgeon General recommended stopping elective surgery on March 14, 2020.

Hip and knee arthroplasties are two of the most commonly performed elective procedures in the US, with approximately 1.5 million procedures performed annually [10,11]. Thousands of patients suffering from the daily pain of arthritis were affected and the true impact of the pandemic on these patients is unmeasured. The American Association of Hip and Knee Surgeons sought to understand the impact these postponements have had on our patient population. The anxiety induced by the pandemic is well documented among health care workers [12] but poorly understood among patients. The aim of the present study was to identify hip and knee arthroplasty patients across many different institutions in the US who had their scheduled primary joint arthroplasty postponed or canceled because of the COVID-19 pandemic guidelines for elective surgery and assess their pain, anxiety, physical function, and economic ability to undergo a delayed operation once the threat of COVID-19 has subsided.

Methods

We administered a novel questionnaire to our elective hip and knee patients affected by the COVID-19 pandemic. Participating centers were identified through the American Association of Hip and Knee Surgeons Research Committee and Research Consortium. Six centers participated in the study. These institutions represent both academic and private medical centers in varied regions throughout the US (Table 1 ). Each institution submitted and obtained local IRB approval or exemption for the study, and all sites signed a standardized data use and transfer agreement with the host institution (the University of Iowa).

Table 1.

Participating Sites.

Institution Region Surgeons (n) Surveys (n)
University of Arkansas for Medical Sciences Midwest 2 53
University of Florida South 5 52
University of Iowa Hospitals and Clinics Midwest 4 58
University of Maryland Northeast 5 9
Hospital for Joint Diseases, New York University Northeast 21 43
Rothman Institute Northeast 45 144
82 359

One survey was completed from a seventh institution and was counted in the frequency but not in the analysis

Inclusion criteria for the study were patients scheduled for primary elective hip or knee arthroplasty in the Spring of 2020 who had their surgery postponed or canceled because of the COVID-19 pandemic. No protected health information was collected from any patient. The survey (Figure 1 ) was distributed to patients electronically or over the telephone with REDCap (Research Electronic Data Capture, Nashville, TN) hosted at the University of Iowa. The survey contained questions regarding the prior planned operation, questions on a 5-point Likert scale [13] addressing anxiety around COVID-19 and the canceled operation, questions about the patients' disease state, and socioeconomic concerns. Data were collected from April 6 to April 15, 2020, before analysis. Surveys were considered complete and included in the study only if all questions were answered on the form.

Fig. 1.

Fig. 1

Fig. 1

Survey instrument that was distributed to patients electronically. COVID-19, coronavirus SARS-CoV-2. FMLA, Family and Medical Leave Act.

Descriptive statistics were performed for the frequency of each survey question and reported as mean ± standard deviation. For the 5 questions that addressed anxiety around COVID-19, responses from the Likert scale were analyzed as categorical responses and also turned to a continuous variable with mean presented (1 = no anxiety to 5 = severe anxiety). Univariate analyses were performed with age (younger than 65 years versus 65 years and older) and with US geographic region (Midwest, Northeast, and South). We used the chi-squared test to detect the relationship between age and region group for each of the categorical variables. The Wilcoxon rank sum test or Kruskal-Wallis test was used to compare the differences for continuous variables among these same groups. All statistical analyses were performed using SAS 9.4 (SAS Inc. Cary, NC) with significance level at P < .05.

Results

Six centers distributed surveys, representing 82 hip and knee surgeons. Surveys were completed successfully by 360 patients. Mean age of the patients was 65 years (33-89 years), 208 (58%) were female, and 158 were scheduled for total hip arthroplasty (THA) (44%) and 202 for total knee arthroplasty (TKA) (56%). Patients were originally scheduled for March (39%), April (53%), and May (8%). Less than one percent of the patients who responded were originally scheduled for June or later. Most patients had their surgery postponed or canceled by the surgeon or hospital (308, 86%), whereas 14% of patients initiated the cancellation. Older patients were more likely to have initiated the cancellation of their operation than younger patients (18% vs 10%, P = .013). The cancellation reason was significantly different in the Northeast and South, with 18% and 25% of cancellations initiated by the patient compared with 3% for Midwest (P < .0001).

Anxiety Around COVID-19

Overall, not knowing when the canceled joint arthroplasty will be rescheduled was rated as the highest source of anxiety (3.4 ± 1.4). Not knowing when the procedure will be rescheduled caused moderate or severe anxiety in 217 patients (60%). Becoming infected with COVID-19 (3.0 ± 1.3) and spreading infection to others (3.1 ± 1.4) were also high causes for anxiety. Patients were least concerned with finances (2.3 ± 1.3) and job security/disability (1.8 ± 1.2).

There were significant differences in the responses by both age and region (Table 2, Table 3 ). For the younger cohort, the questions about finances (2.7 ± 1.3 vs 1.9 ± 1.1, P < .0001) and job insecurity (2.3 ± 1.3 vs 1.4 ± 0.9, P < .0001) caused significantly more anxiety than in the older group. In the Northeast, patients had significantly higher anxiety around becoming infected with COVID-19 (3.2 ± 1.3 compared with 2.7 ± 1.2 for Midwest and 2.8 ± 1.3 for South, P = .004).

Table 2.

Responses by Age <65 y vs 65 y or Older.

Question Age <65 y
Age 65+ y
P Value OR (95% CI)
175 (49%)a 185 (51%)
Region
 Midwest 61 50 .13
 Northeast 93 103
 South 20 32
Joint
 Hip 72 86 .31
 Knee 103 99
Surgery planned
 March 61 79 .30
 April 96 93
 May 17 11
 June 1 2
Who canceled?
 Surgeon 158 150 .013
 Self 17 35
Becoming infected
 1 – no anxiety 25 22 .79
 2 – minimal 50 56
 3 – neutral 28 23
 4 – moderate 51 61
 5 – severe 21 23
Spreading infection
 1 – no anxiety 31 28 .82
 2 – minimal 47 51
 3 – neutral 11 13
 4 – moderate 50 61
 5 – severe 36 32
Finances
 1 – no anxiety 43 100 <.0001
 2 – minimal 44 36
 3 – neutral 24 21
 4 – moderate 48 22
 5 – severe 16 6
Job security
 1 – no anxiety 73 144 <.0001
 2 – minimal 33 16
 3 – neutral 29 17
 4 – moderate 30 6
 5 – severe 10 2
Not knowing
 1 – no anxiety 21 32 .0095
 2 – minimal 21 33
 3 – neutral 19 17
 4 – moderate 63 76
 5 – severe 51 27
Arthritis pain change?
 Increased 102 94 .26
 Decreased 4 8
 Stayed same 69 83
Surgery in spite of COVID?
 Yes 71 40 <.0001 2.5 (1.6-3.9)
 No 104 145
Agree with no elective OR?
 Yes 144 163 .12
 No 31 22
Feeling isolated?
 No 41 33 .19
 Yes 134 152
Have help at home?
 No 32 22 .09
 Yes 143 163
Activity level changed?
 Increased 21 10 .08
 Decreased 85 94
 Stayed same 69 81
Rescheduling?
 No delay 154 162 .08
 COVID fear 7 16
 Financial 4 1
 PTO 3 0
 Other 7 6

COVID, novel coronavirus SARS-CoV-2. OR, operating rooms; PTO, paid time off. Values in bold represent P < .05.

a

One survey was completed from a seventh institution and was counted in the frequency but not in the analysis.

Table 3.

Responses by US Region.

Question Midwest
Northeast
South
P Value
111 (31%) 196 (55%)a 52 (14%)
Joint
 Hip 49 92 17 .18
 Knee 62 104 35
Surgery planned
 March 34 93 13 <.0001
 April 65 99 24
 May 12 1 15
 June 0 3 0
Who canceled?
 Surgeon 108 160 39 <.0001
 Self 3 36 13
Becoming infected
 1 – no anxiety 17 21 9 .06
 2 – minimal 39 51 16
 3 – neutral 20 25 6
 4 – moderate 28 66 17
 5 – severe 7 33 4
Spreading infection
 1 – no anxiety 15 30 13 .043
 2 – minimal 40 48 10
 3 – neutral 6 12 6
 4 – moderate 35 66 10
 5 – severe 15 40 13
Finances
 1 – no anxiety 54 66 22 .19
 2 – minimal 19 47 14
 3 – neutral 13 27 5
 4 – moderate 19 45 6
 5 – severe 6 11 5
Job security
 1 – no anxiety 69 110 37 .13
 2 – minimal 13 27 9
 3 – neutral 13 31 2
 4 – moderate 12 23 1
 5 – severe 4 5 3
Not knowing
 1 – no anxiety 23 23 7 .08
 2 – minimal 18 29 7
 3 – neutral 9 21 6
 4 – moderate 47 77 15
 5 – severe 14 46 17
Arthritis pain change?
 Increased 58 111 26 .91
 Decreased 4 6 2
 Stayed same 49 79 24
Surgery in spite of COVID?
 Yes 36 60 15 .89
 No 75 136 37
Agree with no elective OR?
 Yes 97 163 47 .34
 No 14 33 5
Feeling isolated?
 No 27 37 9 .44
 Yes 84 159 43
Have help at home?
 No 94 163 48 .26
 Yes 17 33 4
Activity level changed?
 Increased 15 11 4 .07
 Decreased 45 106 28
 Stayed same 51 79 20
Rescheduling?
 No delay 95 173 47 .92
 COVID fear 7 12 4
 Financial 2 3 0
 PTO 1 2 0
 Other 6 6 1

COVID, novel coronavirus SARS-CoV-2. Values in bold represent P < .05.

a

One survey was completed from a seventh institution and was counted in the frequency but not in the analysis.

Arthritis Symptoms in Light of COVID-19

Most patients stated that their pain from hip/knee arthritis has increased since surgery cancellation (54%), and 30% stated that they would have proceeded with surgery in spite of the risks posed by COVID-19. Activity levels have decreased for 50% of the participants since cancellation. Although most patients have help at home assisting with activities of daily living, 15% of the respondents were without help at home and 21% of patients felt isolated or lonely as a result. There were no significant differences between age groups or regions.

Public Health Measures and COVID-19

Patients varied in responses to further efforts to curb the spread of COVID-19. Most patients (85%) agreed with the decision to stop elective procedures in the face of ongoing pandemic. There were no differences in age or region for these responses.

Patient Plans for Future Treatment

When asked about future plans for arthritis treatment, 316 patients (88%) stated they will reschedule surgery in the near future. Only 23 patients (6%) wished to delay further for fear of COVID-19, 5 patients (1%) wished to delay for financial reasons, 3 patients (1%) to accrue more paid time off. There were no differences in age or regional responses.

Discussion

As of April 15, 2020, the global COVID-19 pandemic caused by the SARS-CoV-2 virus has caused 1.9 million infections and 123,010 deaths globally [14], with 579,005 confirmed cases and 22,252 deaths in the US [15]. Projections of critical care shortages throughout the US [16], and as a result, drastic public health measures designed to slow its spread [7,9] led to a dramatic shift in the practice of hip and knee arthroplasty surgeons in the US. The broad recommendation to postpone elective operations in the US during the pandemic has led to a large cohort of patients with end-stage hip and knee arthritis that can no longer receive their recommended surgical treatment. By some estimations, as many as 150,000 patients will have their elective hip/knee arthroplasty postponed per month while the elective moratorium lasts [10]. In this study, we aimed to focus on these patients and their responses to the anxiety caused by COVID-19, their daily disease burden from lower extremity arthritis, and their future focus for rescheduling the planned procedure.

We found that most patients had their operation postponed by their surgeon, although patients from regions harder hit by the pandemic were more likely to have canceled their own surgery (18% cancellation in Northeast urban areas compared with 3% for the rural Midwest). Older patients at higher risk if contracting COVID-19 were also more likely to cancel themselves compared with younger patients (18% vs 10%). Patient anxiety was most focused on the unknown timing for future scheduling across regions. Younger patients were significantly more concerned with finances and job security. Patients from the urban Northeast region were more concerned with becoming infected by the virus. The daily symptoms of arthritis were unchanged or exacerbated in most patients, and limitations at home were significant for 15%-20%. The drastic public health measures taken by state and federal government to slow the spread of COVID-19 were understood by the patients, but almost 90% of the respondents replied that they would like their surgery rescheduled in the near future.

The present study is limited by its small number of patient responses relative to the predicted number of canceled cases and the homogeneity of the participating sites. Continued work will occur over the next few months to distribute the survey more broadly and to further understand the effect the COVID-19 pandemic has had on our patients. With more patients, we hope to validate this initial study and perform more in-depth subgroup analyses. A second limitation includes the fact that survey administration was mixed between online completion and telephone review of the questions by a member of the surgeon’s team. It is possible that the discrepancies in administration techniques could bias patient responses.

Conclusion

The COVID-19 pandemic has had a dramatic effect on everyday life in the US and the rest of the world and has affected hip and knee surgeons, their practices, and most importantly our patients. From the present study, we conclude that patients clearly have anxiety related to the COVID-19 pandemic and continue to suffer from the effects of lower extremity arthritis while at home. Stark regional differences exist in the burden of COVID-19 in the US, and this is seen in our patient’s responses. Patient age also plays a large role in the reaction to the pandemic, particularly in regard to financial and job security concerns. This pilot study will be expanded to include all regions of the country and larger numbers of patients in the ensuing weeks before arthroplasty surgeons resume the performance of elective joint arthroplasty surgery.

Footnotes

This article is published as part of a supplement supported by the American Association of Hip and Knee Surgeons and by an educational grant from Aerobiotix.

One or more of the authors of this paper have disclosed potential or pertinent conflicts of interest, which may include receipt of payment, either direct or indirect, institutional support, or association with an entity in the biomedical field which may be perceived to have potential conflict of interest with this work. For full disclosure statements refer to https://doi.org/10.1016/j.arth.2020.04.052.

Appendix A. Supplementary Data

Conflict of Interest Statement for Mears
mmc1.docx (17.4KB, docx)
Conflict of Interest Statement for Edwards
mmc2.pdf (128.4KB, pdf)
Conflict of Interest Statement for Schwarzkopf
mmc3.docx (17.4KB, docx)
Conflict of Interest Statement for Brown
mmc4.pdf (99KB, pdf)
Conflict of Interest Statement for Parvizi
mmc5.docx (17.5KB, docx)
Conflict of Interest Statement for Rojas
mmc6.pdf (1.8MB, pdf)
Conflict of Interest Statement for Prieto
mmc7.pdf (139KB, pdf)
Conflict of Interest Statement for Barnes
mmc8.docx (16.4KB, docx)
Conflict of Interest Statement for Nandi
mmc9.pdf (107.3KB, pdf)
Conflict of Interest Statement for Stambough
mmc10.docx (1.2MB, docx)
Conflict of Interest Statement for Anthony
mmc11.pdf (206.9KB, pdf)
Conflict of Interest Statement for Bedard
mmc12.pdf (39.5KB, pdf)

References

  • 1.Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gates B. Responding to Covid-19 - a once-in-a-Century pandemic? N Engl J Med. 2020 doi: 10.1056/NEJMp2003762. [E-pub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 3.Fauci A.S., Lane H.C., Redfield R.R. Covid-19 - navigating the uncharted. N Engl J Med. 2020;382:1268–1269. doi: 10.1056/NEJMe2002387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Grasselli G., Pesenti A., Cecconi M. Critical care utilization for the COVID-19 outbreak in lombardy, Italy: early experience and Forecast during an emergency response. JAMA. 2020 doi: 10.1001/jama.2020.4031. [E-pub ahead of print] [DOI] [PubMed] [Google Scholar]
  • 5.Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. China medical treatment expert group for C. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. [E-pub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Song J.Y., Yun J.G., Noh J.Y., Cheong H.J., Kim W.J. Covid-19 in South Korea - challenges of subclinical manifestations. N Engl J Med. 2020 doi: 10.1056/NEJMc2001801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pan A., Liu L., Wang C., Guo H., Hao X., Wang Q. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.6130. [E-pub ahead of print] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Omer S.B., Malani P., Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA. 2020 doi: 10.1001/jama.2020.5788. [DOI] [PubMed] [Google Scholar]
  • 9.Gostin L.O., Hodge J.G., Jr. US emergency legal responses to novel coronavirus: Balancing public health and Civil liberties. JAMA. 2020 doi: 10.1001/jama.2020.2025. [DOI] [PubMed] [Google Scholar]
  • 10.Kurtz S.M., Ong K.L., Lau E., Bozic K.J. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am. 2014;96:624–630. doi: 10.2106/JBJS.M.00285. [DOI] [PubMed] [Google Scholar]
  • 11.Sloan M., Premkumar A., Sheth N.P. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am. 2018;100:1455–1460. doi: 10.2106/JBJS.17.01617. [DOI] [PubMed] [Google Scholar]
  • 12.Shanafelt T., Ripp J., Trockel M. Understanding and addressing sources of anxiety among health care professionals during the COVID-19 pandemic. JAMA. 2020 doi: 10.1001/jama.2020.5893. [DOI] [PubMed] [Google Scholar]
  • 13.Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;140:1–55. [Google Scholar]
  • 14.WHO . 2020. Coronavirus Disease 2019 (COVID-19) Situation Report - 85.https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200415-sitrep-86-covid-19.pdf?sfvrsn=c615ea20_2 [accessed 15.05.20] [Google Scholar]
  • 15.CDC . 2020. Coronavirus Disease 2019 (COVID-19): Cases in U.S.https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html [accessed 150.05.20] [Google Scholar]
  • 16.Moghadas S.M., Shoukat A., Fitzpatrick M.C., Wells C.R., Sah P., Pandey A. Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proc Natl Acad Sci U S A. 2020 doi: 10.1073/pnas.2004064117. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Conflict of Interest Statement for Mears
mmc1.docx (17.4KB, docx)
Conflict of Interest Statement for Edwards
mmc2.pdf (128.4KB, pdf)
Conflict of Interest Statement for Schwarzkopf
mmc3.docx (17.4KB, docx)
Conflict of Interest Statement for Brown
mmc4.pdf (99KB, pdf)
Conflict of Interest Statement for Parvizi
mmc5.docx (17.5KB, docx)
Conflict of Interest Statement for Rojas
mmc6.pdf (1.8MB, pdf)
Conflict of Interest Statement for Prieto
mmc7.pdf (139KB, pdf)
Conflict of Interest Statement for Barnes
mmc8.docx (16.4KB, docx)
Conflict of Interest Statement for Nandi
mmc9.pdf (107.3KB, pdf)
Conflict of Interest Statement for Stambough
mmc10.docx (1.2MB, docx)
Conflict of Interest Statement for Anthony
mmc11.pdf (206.9KB, pdf)
Conflict of Interest Statement for Bedard
mmc12.pdf (39.5KB, pdf)

Articles from The Journal of Arthroplasty are provided here courtesy of Elsevier

RESOURCES